Interviews

Pfizer’s $31 billion bond sale to fund its $43 billion acquisition of cancer drug maker Seagen is one of the largest in history. Healthcare expert Séverine Piot-Deval discusses the deal with Global Finance.  

Ben T. Smith IV, a longtime Silicon Valley executive and currently head of the Communications, Media and Technology practice at Kearney, speaks to Global Finance about the post-SVB venture capital industry and the pace of innovation.

Are luxury cars untouched by economic slowdown and inflation? The latest results from Italian luxury automaker Lamborghini suggests so. CFO Paolo Poma believes the company can even improve its profitability, despite economic headwinds. Global Finance spoke with Poma—who has been managing director and CFO since 2017—when he recently visited New York.

Where might the next shoe drop in the banking sector? Accelerate CEO and ETF specialist Julian Klymochko has some surprising answers.

Chris Miller, author of the recently released book Chip War, explains the complexities and ramifications of international competition for dominance in the critical technology of semiconductors.